Literature DB >> 29576174

Advances in Juvenile Dermatomyositis: Myositis Specific Antibodies Aid in Understanding Disease Heterogeneity.

Lauren M Pachman1, Amer M Khojah2.   

Abstract

Entities:  

Keywords:  pathophysiology; physical signs; treatment

Mesh：

Substances：

Year:  2018        PMID： 29576174      PMCID： PMC5881602          DOI： 10.1016/j.jpeds.2017.12.053

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  141 in total

1.  Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference.

Authors:  Adam M Huber; Angela B Robinson; Ann M Reed; Leslie Abramson; Sharon Bout-Tabaku; Ruy Carrasco; Megan Curran; Brian M Feldman; Harry Gewanter; Thomas Griffin; Kathleen Haines; Mark F Hoeltzel; Josephine Isgro; Philip Kahn; Bianca Lang; Patti Lawler; Bracha Shaham; Heinrike Schmeling; Rosie Scuccimarri; Michael Shishov; Elizabeth Stringer; Julie Wohrley; Norman T Ilowite; Carol Wallace
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-04       Impact factor: 4.794

2.  History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry.

Authors:  Lauren M Pachman; Rebecca Lipton; Rosalind Ramsey-Goldman; Eli Shamiyeh; Kathy Abbott; Eduardo P Mendez; Alan Dyer; Deborah Mc Curdy; Larry Vogler; Ann Reed; Gail Cawkwell; Lawrence Zemel; Christy Sandborg; Rafael Rivas-Chacon; Christine Hom; Norman Ilowite; Abraham Gedalia; Jonathan Gitlin; Michael Borzy
Journal:  Arthritis Rheum       Date:  2005-04-15

Review 3.  Incidence and prevalence of inflammatory myopathies: a systematic review.

Authors:  Alain Meyer; Nicolas Meyer; Mickael Schaeffer; Jacques-Eric Gottenberg; Bernard Geny; Jean Sibilia
Journal:  Rheumatology (Oxford)       Date:  2014-07-26       Impact factor: 7.580

Review 4.  Climate change and human infectious diseases: A synthesis of research findings from global and spatio-temporal perspectives.

Authors:  Lu Liang; Peng Gong
Journal:  Environ Int       Date:  2017-03-23       Impact factor: 9.621

5.  Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis.

Authors:  Rochella A Ostrowski; Christine L Sullivan; Roopa Seshadri; Gabrielle A Morgan; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2010-05

6.  Race, Income, and Disease Outcomes in Juvenile Dermatomyositis.

Authors:  Kathryn Phillippi; Mark Hoeltzel; Angela Byun Robinson; Susan Kim
Journal:  J Pediatr       Date:  2017-03-03       Impact factor: 4.406

7.  Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).

Authors:  Michael F Marmor; Ulrich Kellner; Timothy Y Y Lai; Ronald B Melles; William F Mieler
Journal:  Ophthalmology       Date:  2016-03-16       Impact factor: 12.079

8.  Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset.

Authors:  C Manlhiot; L Liang; D Tran; A Bitnun; P N Tyrrell; B M Feldman
Journal:  Rheumatology (Oxford)       Date:  2008-02-27       Impact factor: 7.580

9.  Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis.

Authors:  Stéphanie Christen-Zaech; Roopa Seshadri; Joyce Sundberg; Amy S Paller; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2008-02

10.  HLA class II alleles may influence susceptibility to adult dermatomyositis and polymyositis in a Han Chinese population.

Authors:  Xiang Gao; Lei Han; Lan Yuan; Yongchen Yang; Guimei Gou; Hengjuan Sun; Ling Lu; Liming Bao
Journal:  BMC Dermatol       Date:  2014-06-04
View more
  22 in total

1.  Dysregulated NK cell PLCγ2 signaling and activity in juvenile dermatomyositis.

Authors:  Allison A Throm; Joshua B Alinger; Jeanette T Pingel; Allyssa L Daugherty; Lauren M Pachman; Anthony R French
Journal:  JCI Insight       Date:  2018-11-15

Review 2.  Advances Toward Precision Medicine in Juvenile Dermatomyositis.

Authors:  Jessica Neely; Susan Kim
Journal:  Curr Rheumatol Rep       Date:  2019-12-07       Impact factor: 4.592

3.  Long-term outcomes in Juvenile Myositis patients.

Authors:  Vladislav Tsaltskan; Annette Aldous; Sam Serafi; Anna Yakovleva; Heidi Sami; Gulnara Mamyrova; Ira N Targoff; Adam Schiffenbauer; Frederick W Miller; Samuel J Simmens; Rodolfo Curiel; Olcay Y Jones; Lisa G Rider
Journal:  Semin Arthritis Rheum       Date:  2019-06-28       Impact factor: 5.532

4.  Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis.

Authors:  Sara Sabbagh; Iago Pinal-Fernandez; Lisa G Rider; Andrew Lee Mammen; Takayuki Kishi; Ira N Targoff; Frederick W Miller
Journal:  Ann Rheum Dis       Date:  2019-04-24       Impact factor: 19.103

5.  Phage display of environmental protein toxins and virulence factors reveals the prevalence, persistence, and genetics of antibody responses.

Authors:  Julia W Angkeow; Daniel R Monaco; Athena Chen; Thiagarajan Venkataraman; Sahana Jayaraman; Cristian Valencia; Brandon M Sie; Thomas Liechti; Payam N Farhadi; Gabriela Funez-dePagnier; Cheryl A Sherman-Baust; May Q Wong; Ingo Ruczinski; Patrizio Caturegli; Cynthia L Sears; Patricia J Simner; June L Round; Priya Duggal; Uri Laserson; Theodore S Steiner; Ranjan Sen; Thomas E Lloyd; Mario Roederer; Andrew L Mammen; Randy S Longman; Lisa G Rider; H Benjamin Larman
Journal:  Immunity       Date:  2022-05-31       Impact factor: 43.474

6.  Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry.

Authors:  Jessica Neely; Kaveh Ardalan; Adam Huber; Susan Kim
Journal:  Pediatr Rheumatol Online J       Date:  2022-07-19       Impact factor: 3.413

7.  Preliminary validation of muscle ultrasound in juvenile dermatomyositis (JDM).

Authors:  Gulnara Mamyrova; Erica McBride; Lawrence Yao; Joseph A Shrader; Minal Jain; Jianhua Yao; Rodolfo V Curiel; Frederick W Miller; Michael O Harris-Love; Lisa G Rider
Journal:  Rheumatology (Oxford)       Date:  2022-04-18       Impact factor: 7.046

Review 8.  Impact of Climate Change on Eye Diseases and Associated Economical Costs.

Authors:  Lucía Echevarría-Lucas; José Mᵃ Senciales-González; María Eloísa Medialdea-Hurtado; Jesús Rodrigo-Comino
Journal:  Int J Environ Res Public Health       Date:  2021-07-05       Impact factor: 3.390

9.  Distinct tissue injury patterns in juvenile dermatomyositis auto-antibody subgroups.

Authors:  Mailan Nguyen; Vy Do; Paul C Yell; Chanhee Jo; Jie Liu; Dennis K Burns; Tracey Wright; Chunyu Cai
Journal:  Acta Neuropathol Commun       Date:  2020-08-05       Impact factor: 7.801

10.  Serum biomarkers of glucocorticoid response and safety in anti-neutrophil cytoplasmic antibody-associated vasculitis and juvenile dermatomyositis.

Authors:  Laurie S Conklin; Peter A Merkel; Lauren M Pachman; Hemang Parikh; Shefa Tawalbeh; Jesse M Damsker; David D Cuthbertson; Gabrielle A Morgan; Paul A Monach; Yetrib Hathout; Kanneboyina Nagaraju; John van den Anker; Carol A McAlear; Eric P Hoffman
Journal:  Steroids       Date:  2018-10-21       Impact factor: 2.668
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.